ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1
+$27.6M
2
+$20.5M
3
+$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

1
+$105M
2
+$14.6M
3
+$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

1 Healthcare 87.7%
2 Financials 1.74%
3 Communication Services 0.1%
4 Consumer Discretionary 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
101
Wave Life Sciences
WVE
$2.57B
$872K 0.09%
119,067
+4,253
PHVS icon
102
Pharvaris
PHVS
$1.82B
$851K 0.08%
34,124
LLY icon
103
Eli Lilly
LLY
$960B
$763K 0.08%
1,000
+500
LRMR icon
104
Larimar Therapeutics
LRMR
$435M
$761K 0.08%
235,689
-1,916
SRRK icon
105
Scholar Rock
SRRK
$4.44B
$748K 0.07%
20,087
-19,590
DNLI icon
106
Denali Therapeutics
DNLI
$3.28B
$748K 0.07%
51,516
+15,800
ACRS icon
107
Aclaris Therapeutics
ACRS
$330M
$710K 0.07%
+373,682
LITS
108
Lite Strategy Inc
LITS
$40.7M
$708K 0.07%
+292,397
ARVN icon
109
Arvinas
ARVN
$860M
$704K 0.07%
82,591
-46,176
URGN icon
110
UroGen Pharma
URGN
$890M
$698K 0.07%
35,000
+25,000
SUPN icon
111
Supernus Pharmaceuticals
SUPN
$3.17B
$689K 0.07%
+14,418
DAY
112
DELISTED
Dayforce
DAY
$689K 0.07%
+10,000
MAZE
113
Maze Therapeutics
MAZE
$2.19B
$675K 0.07%
+26,045
EWTX icon
114
Edgewise Therapeutics
EWTX
$3.14B
$649K 0.06%
40,000
BABA icon
115
Alibaba
BABA
$340B
$639K 0.06%
+3,578
GERN icon
116
Geron
GERN
$989M
$625K 0.06%
456,176
+15,000
SPRY icon
117
ARS Pharmaceuticals
SPRY
$906M
$595K 0.06%
+59,230
SYRE icon
118
Spyre Therapeutics
SYRE
$3.34B
$571K 0.06%
34,051
GOSS icon
119
Gossamer Bio
GOSS
$99.2M
$559K 0.06%
212,531
-14,697
AEXA
120
American Exceptionalism Acquisition Corp
AEXA
$547M
$547K 0.05%
+50,000
IDYA icon
121
IDEAYA Biosciences
IDYA
$2.9B
$544K 0.05%
+20,000
LENZ
122
LENZ Therapeutics
LENZ
$428M
$541K 0.05%
+11,619
NGNE icon
123
Neurogene
NGNE
$321M
$531K 0.05%
30,633
+1,008
BHF icon
124
Brighthouse Financial
BHF
$3.43B
$531K 0.05%
+10,000
GTERU
125
Globa Terra Acquisition Corp Units
GTERU
$158M
$509K 0.05%
+50,000
3 4
5
6 7